Agenus shared a post on LinkedIn:
“Honoring Investigator-Led Innovation in CRC
We’re inspired by the work of Nicholas DeVito, MD, and his team, whose investigator-initiated study is exploring BOT/BAL immunotherapy prior to chemotherapy and surgery for MSS colorectal cancer.
Watch this moving patient story from Gateway’s annual gala.
This research, supported by Gateway for Cancer Research, represents the power of clinician-driven innovation to reimagine care and reduce treatment burden for patients.”
More posts featuring Agenus.
